A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke

NCT01297413 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Stemedica Cell Technologies, Inc.

Collaborators